Poseida Therapeutics PSTX 深 滬
已收盤 09-19 16:00:00 美东时间
3.61
+0.100
+2.85%
華盛通- 最 高3.78
- 今 開3.56
- 成交量 60.19万股
- 最 低 3.42
- 昨 收 3.51
- 總市值 3.44亿
- 52周最高 4.27
- 市盈率 靜 --
- 換手率 0.63%
- 52周最低 1.83
- 委 比 -91.61%
- 總股本 9524.95万
- 歷史最高 17.62
- 量 比 1.16
- 振 幅 10.26%
- 歷史最低 1.54
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | poseida therapeutics将在第21届国际骨髓瘤学会年会上发布关于Allogeneic CAR-t P-BCMA-ALLO1的临床试验阶段1的新数据，该试验用于治疗复发/难治性多发性骨髓瘤的患者
Poseida Therapeutics to Present New Clinical Data From Phase 1 Study of Allogen...
09-05 21:00
快讯 | Poseida Therapeutics Inc - 在多发性骨髓瘤患者中启动P-BCMA-ALLO1第10亿期临床试验，并从罗氏获得2000万美元的支付。
Poseida Therapeutics Inc - Initiates P-BCMA-ALLO1 Phase 1B Clinical Trial in Pa...
09-05 21:00
快讯 | poseida therapeutics - 销售协议招股书包括根据协议发行的最多8500万美元普通股的发行
Poseida Therapeutics - Sales Agreement Prospectus Covers Offering of up to $85....
08-06 04:36
快讯 | Poseida Therapeutics公司申请混合式最高达3亿美元的股票发行 – 根据SEC文件
Poseida Therapeutics Inc Files for Mixed Shelf of up to $300 Mln – SEC Filing
08-06 04:35
快讯 | poseida therapeutics第二季度基本每股收益为美元指数-0.32。
Poseida Therapeutics Q2 Basic EPS USD -0.32
08-06 04:05
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
SAN DIEGO, June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral t...
06-04 04:05
Malin Investee Poseida Forges Major Biotech Alliance
Malin Corporation PLC (MLLNF) has released an update. Malin Corporation PLC has...
05-02 01:01
HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target
HC Wainwright & Co. analyst Arthur He reiterates Poseida Therapeutics (NASDAQ:PSTX) with a Buy and maintains $20 price target.
04-22 18:40
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers
Gainers: Palisade Bio (PALI) +97%. Marinus Pharmaceuticals (MRNS) +21%. Intra-Cellular Therapies (ITCI) +22%. Cullinan Oncology (CGEM) +21%. IMAC Holdings (BACK) +26%. Losers: Pacific Biosciences of C...
04-16 22:00
Poseida Therapeutics (PSTX) Gets a Buy from William Blair
In a report released today, Sami Corwin from William Blair maintained a Buy rat...
04-09 05:25
